B
2.71
0.04 (1.69%)
| Previous Close | 2.66 |
| Open | 2.69 |
| Volume | 81,892 |
| Avg. Volume (3M) | 128,871 |
| Market Cap | 129,437,776 |
| Price / Earnings (TTM) | 3.42 |
| Price / Earnings (Forward) | 6.61 |
| Price / Sales | 0.490 |
| 52 Weeks Range | |
| Earnings Date | 5 Nov 2025 |
| Profit Margin | 10.55% |
| Operating Margin (TTM) | 19.78% |
| Diluted EPS (TTM) | 0.580 |
| Quarterly Revenue Growth (YOY) | 4.70% |
| Quarterly Earnings Growth (YOY) | -52.10% |
| Current Ratio (MRQ) | 1.42 |
| Operating Cash Flow (TTM) | 44.34 M |
| Levered Free Cash Flow (TTM) | 54.17 M |
| Return on Assets (TTM) | 16.29% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Medical Care Facilities (US) | Mixed | Mixed |
| Medical Care Facilities (Global) | Mixed | Mixed | |
| Stock | Biote Corp. | Bearish | Bearish |
AIStockmoo Score
-0.9
| Analyst Consensus | -2.0 |
| Insider Activity | NA |
| Price Volatility | 0.5 |
| Technical Moving Averages | 0.0 |
| Technical Oscillators | -2.0 |
| Average | -0.88 |
|
Biote Corp operates a growth practice-building business within the hormone optimization space. It provides the necessary components to enable Biote-certified practitioners to establish, build, and successfully implement a program designed to optimize hormone levels using personalized solutions for their patient populations. The company derives revenue from United States and also has its presence in other countries. |
|
| Sector | Healthcare |
| Industry | Medical Care Facilities |
| Investment Style | Small Value |
| % Held by Insiders | 13.02% |
| % Held by Institutions | 65.98% |
No data within this time range.
No data within this time range.
| Date | Type | Details |
|---|---|---|
| 05 Nov 2025 | Announcement | Biote Reports Third Quarter 2025 Financial Results |
| 22 Oct 2025 | Announcement | Biote Schedules Third Quarter 2025 Financial Results Release and Conference Call |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2025 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |